Breaking News Instant updates and real-time market news.

CARA

Cara Therapeutics

$17.96

0.12 (0.67%)

16:21
08/07/18
08/07
16:21
08/07/18
16:21

Cara Therapeutics reports Q2 EPS (52c), consensus (32c)

Reports Q2 revenue $2.87M, consensus $6.47M.

  • 07

    Aug

  • 30

    Aug

  • 31

    Aug

CARA Cara Therapeutics
$17.96

0.12 (0.67%)

05/23/18
HCWC
05/23/18
NO CHANGE
Target $24
HCWC
Buy
H.C. Wainwright says Cara found 'best possible' partner, ups target to $24
H.C. Wainwright analyst Oren Livnat said Cara Therapeutics selected the "best possible partner to maximize IV Korsuva" in signing an agreement with the Vifor/Fresenius joint venture. He views the deal as a "clear positive," stating that it brings in minimally dilutive financing, validates Korsuva, and de-risks the U.S. commercial launch. Livnat increased his price target on Cara shares to $24 from $22 and keeps a Buy rating on the stock.
06/27/18
NEED
06/27/18
NO CHANGE
NEED
Cara Therapeutics price target raised to $28 from $23 at Needham
Needham analyst Alan Carr maintained a Buy rating on Cara Therapeutics and raised his price target on shares to $28 from $23, following positive results from Cara's Phase 3 trial of IV CR845 in Post-Surgical Pain, which met its primary endpoint and showed statistically significant impact on Post-Operative Nausea and Vomiting.
06/28/18
HCWC
06/28/18
NO CHANGE
Target $26
HCWC
Cara Therapeutics price target raised to $26 from $24 at H.C. Wainwright
H.C. Wainwright analyst Oren Livnat raised his price target for Cara Therapeutics to $26 saying the company yesterday surprised the Street with a positive IV CR845 Phase 2/3 postoperative pain study. The positive pain trial "certainly adds upside optionality to the story," Livnat tells investors in a research note. He notes, however, that there remains several open questions about the product profile regarding efficacy and potential indication to pursue. Livnat keeps a Buy rating on Cara.
06/28/18
NEED
06/28/18
NO CHANGE
Target $28
NEED
Buy
Cara Therapeutics price target raised to $28 from $23 at Needham
Needham analyst Alan Carr raised his price target on Cara Therapeutics to $28 and kept his Buy rating, citing the company's update on Phase 3 trial of IV CR845 in post-surgical pain. Carr notes that while the low dose missed statistical significance, it trended favorably relative to placebo, and the high dose met the primary endpoint of pain relief. The analyst sees the profile of CR845 as attractive with effective pain relief, low addiction, and low nausea side effects.

TODAY'S FREE FLY STORIES

ENTA

Enanta

$79.05

2.15 (2.80%)

, ABBV

AbbVie

$89.63

-0.07 (-0.08%)

11:43
11/13/18
11/13
11:43
11/13/18
11:43
Hot Stocks
Enanta announces AbbVie report of MAVYRET data at AASLD »

Enanta Pharmaceuticals…

ENTA

Enanta

$79.05

2.15 (2.80%)

ABBV

AbbVie

$89.63

-0.07 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

GLMD

Galmed

$9.57

0.045 (0.47%)

11:42
11/13/18
11/13
11:42
11/13/18
11:42
Hot Stocks
Galmed trial data on Aramchol 600mg presented at the Liver Meeting »

Galmed Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

INIS

International Isotopes

$0.00

(0.00%)

11:40
11/13/18
11/13
11:40
11/13/18
11:40
Hot Stocks
International Isotopes announces long-term supply agreement for I-131 »

International Isotopes,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$92.96

0.27 (0.29%)

11:40
11/13/18
11/13
11:40
11/13/18
11:40
Options
Repeat call spreads in Procter and Gamble »

Repeat call spreads in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

11:40
11/13/18
11/13
11:40
11/13/18
11:40
General news
U.S. equities have snapped higher »

U.S. equities have…

HXL

Hexcel

$60.93

0.38 (0.63%)

11:38
11/13/18
11/13
11:38
11/13/18
11:38
Conference/Events
Hexcel management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

MSFT

Microsoft

$108.43

1.54 (1.44%)

, NLSN

Nielsen

$26.81

0.38 (1.44%)

11:37
11/13/18
11/13
11:37
11/13/18
11:37
Hot Stocks
Microsoft, Nielsen announce strategic alliance for retail innovation »

Nielsen (NLSN) and…

MSFT

Microsoft

$108.43

1.54 (1.44%)

NLSN

Nielsen

$26.81

0.38 (1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 26

    Nov

  • 28

    Nov

  • 03

    Mar

AAPL

Apple

$196.43

2.275 (1.17%)

11:36
11/13/18
11/13
11:36
11/13/18
11:36
Conference/Events
Apple management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

11:36
11/13/18
11/13
11:36
11/13/18
11:36
General news
3-Month Bill Auction Total Amount data reported »

3-Month Bill Auction…

11:36
11/13/18
11/13
11:36
11/13/18
11:36
General news
6-Month Bill Auction Total Amount data reported »

6-Month Bill Auction…

ABBV

AbbVie

$89.59

-0.11 (-0.12%)

11:34
11/13/18
11/13
11:34
11/13/18
11:34
Hot Stocks
AbbVie says MAVYRET shows high virologic cure rates in treatment-naive HCV »

AbbVie announced new data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNE

Sony

$51.75

0.2 (0.39%)

11:32
11/13/18
11/13
11:32
11/13/18
11:32
Hot Stocks
PlayerUnknown's Battlegrounds, coming to PS4 next month »

In a blog posting by Joon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,670.32

33.62 (2.05%)

, GOOG

Alphabet

$1,053.39

14.17 (1.36%)

11:31
11/13/18
11/13
11:31
11/13/18
11:31
Recommendations
Amazon.com, Alphabet, Alphabet Class A analyst commentary  »

Amazon selection of East…

AMZN

Amazon.com

$1,670.32

33.62 (2.05%)

GOOG

Alphabet

$1,053.39

14.17 (1.36%)

GOOGL

Alphabet Class A

$1,062.87

13.27 (1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Nov

  • 04

    Dec

  • 03

    Mar

11:30
11/13/18
11/13
11:30
11/13/18
11:30
Conference/Events
Morgan Stanley energy analysts to hold an analyst/industry conference call »

Analysts, along with Ari…

VIAB

Viacom

$32.73

0.15 (0.46%)

11:30
11/13/18
11/13
11:30
11/13/18
11:30
Options
15K Jun 25 - 30 put spreads bought for $1.50 ahead of Viacom's earnings »

15K Jun 25 - 30 put…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 04

    Dec

TVPT

Travelport

$15.38

0.39 (2.60%)

11:29
11/13/18
11/13
11:29
11/13/18
11:29
Hot Stocks
Travelport rises after blog report says sale agreement nearing »

Shares of Travelport…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,672.00

35.3 (2.16%)

, C

Citi

$65.11

0.88 (1.37%)

11:27
11/13/18
11/13
11:27
11/13/18
11:27
Hot Stocks
Citi to move 1,1000 employees to make room for Amazon in Long Island City Tower »

Citi (C) announced that…

AMZN

Amazon.com

$1,672.00

35.3 (2.16%)

C

Citi

$65.11

0.88 (1.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 28

    Nov

  • 04

    Dec

  • 14

    Jan

  • 15

    Apr

  • 13

    Jul

SFLY

Shutterfly

$57.09

0.18 (0.32%)

11:25
11/13/18
11/13
11:25
11/13/18
11:25
Conference/Events
Shutterfly to host analyst meeting »

Analyst meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

PDD

Pinduoduo

$17.41

0.2 (1.16%)

11:20
11/13/18
11/13
11:20
11/13/18
11:20
Options
Short-term option buyers in Pinduoduo »

Short-term option buyers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
11/13/18
11/13
11:17
11/13/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
11/13/18
11/13
11:16
11/13/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$199.81

10.44 (5.51%)

, BBY

Best Buy

$67.09

-0.05 (-0.07%)

11:15
11/13/18
11/13
11:15
11/13/18
11:15
OnTheFly
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's top…

NVDA

Nvidia

$199.81

10.44 (5.51%)

BBY

Best Buy

$67.09

-0.05 (-0.07%)

LITE

Lumentum

$40.77

3.265 (8.71%)

AAPL

Apple

$195.83

1.675 (0.86%)

PRGO

Perrigo

$65.20

-0.34 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 15

    Nov

  • 26

    Nov

  • 10

    Dec

NVDA

Nvidia

$199.69

10.32 (5.45%)

11:15
11/13/18
11/13
11:15
11/13/18
11:15
OnTheFly
Fly Intel: What to watch in Nvidia earnings report »

Nvidia (NVDA) is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 26

    Nov

  • 10

    Dec

11:15
11/13/18
11/13
11:15
11/13/18
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

11:15
11/13/18
11/13
11:15
11/13/18
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.